{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:37:47Z","timestamp":1787236667615,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The genetic changes underlying carcinogenesis in patients with risk factors of gallbladder carcinoma (GBC) remains controversial, especially in patients with pancreaticobiliary maljunction (PBM). This study aimed to clarify the association between risk factors of GBC and genetic changes using next-generation sequencing (NGS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed resected tissues of 64 patients who were diagnosed with GBC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926), PBM [with GBC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098), without GBC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920)], and chronic cholecystitis, used as a control group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910). DNA was extracted from tumors and their surrounding tissues, which were precisely separated by laser-capture microdissection. Gene alterations of 50 cancer-related genes were detected by NGS and compared with clinical information, including PBM status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The most frequent gene alterations in GBC tissues occurred in\n                      <jats:italic>TP53<\/jats:italic>\n                      (50%), followed by\n                      <jats:italic>EGFR<\/jats:italic>\n                      (20.6%),\n                      <jats:italic>RB1<\/jats:italic>\n                      (17.6%), and\n                      <jats:italic>ERBB2<\/jats:italic>\n                      (17.6%). Gene alterations that were targetable by molecular targeted drugs were detected in 20 cases (58.8%). Statistical analysis of gene alterations and risk factors revealed that\n                      <jats:italic>TP53<\/jats:italic>\n                      alteration rate was higher in GBC patients with PBM than those without PBM (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.038), and the TP53 mutation rates in the epithelium of control patients, epithelium of PBM patients without GBC, peritumoral mucosa of GBC patients with PBM, and tumor tissue of GBC patients with PBM were 10, 10, 38, and 75%, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>TP53<\/jats:italic>\n                      alteration more than\n                      <jats:italic>KRAS<\/jats:italic>\n                      mutation was revealed to underlie carcinogenesis in patients with PBM.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-09000-2","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T10:03:04Z","timestamp":1637316184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Satoshi","family":"Kawakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuhiko","family":"Kuratomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kadokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Hosomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetake","family":"Amemiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Kawaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"issue":"22","key":"9000_CR1","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","volume":"23","author":"A Sharma","year":"2017","unstructured":"Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017;23(22):3978\u201398. https:\/\/doi.org\/10.3748\/wjg.v23.i22.3978.","journal-title":"World J Gastroenterol"},{"key":"9000_CR2","doi-asserted-by":"publisher","unstructured":"Lau CSM, Zywot A, Mahendraraj K, Chamberlain RS. Gallbladder carcinoma in the United States: a population based clinical outcomes study involving 22,343 patients from the surveillance, epidemiology, and end result database (1973-2013). HPB Surg. 2017;2017. https:\/\/doi.org\/10.1155\/2017\/1532835.","DOI":"10.1155\/2017\/1532835"},{"issue":"3","key":"9000_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jhbp.314","volume":"23","author":"S Ishihara","year":"2016","unstructured":"Ishihara S, Horiguchi A, Miyakawa S, Endo I, Miyazaki M, Takada T. Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci. 2016;23(3):149\u201357. https:\/\/doi.org\/10.1002\/jhbp.314.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"40","key":"9000_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022292","volume":"99","author":"X Zhu","year":"2020","unstructured":"Zhu X, Zhang X, Hu X, Ren H, Wu S, Wu J, et al. Survival analysis of patients with primary gallbladder cancer from 2010 to 2015: a retrospective study based on SEER data. Medicine (Baltimore). 2020;99(40):e22292. https:\/\/doi.org\/10.1097\/MD.0000000000022292.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"9000_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/ijc.21683","volume":"118","author":"G Randi","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591\u2013602. https:\/\/doi.org\/10.1002\/ijc.21683.","journal-title":"Int J Cancer"},{"issue":"4","key":"9000_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/ijc.22756","volume":"121","author":"AW Hsing","year":"2007","unstructured":"Hsing AW, Bai Y, Andreotti G, Rashid A, Deng J, Chen J, et al. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer. 2007;121(4):832\u20138. https:\/\/doi.org\/10.1002\/ijc.22756.","journal-title":"Int J Cancer"},{"issue":"17","key":"9000_CR7","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/nejmoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625\u201338. https:\/\/doi.org\/10.1056\/nejmoa021423.","journal-title":"N Engl J Med"},{"issue":"8","key":"9000_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/apt.12655","volume":"39","author":"V Nagaraja","year":"2014","unstructured":"Nagaraja V, Eslick GD. Systematic review with meta-analysis: the relationship between chronic salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther. 2014;39(8):745\u201350. https:\/\/doi.org\/10.1111\/apt.12655.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"9000_CR9","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/cncr.10893","volume":"95","author":"M Bulajic","year":"2002","unstructured":"Bulajic M, Maisonneuve P, Schneider-Brachert W, M\u00fcller P, Reischl U, Stimec B, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer. 2002;95(9):1946\u201353. https:\/\/doi.org\/10.1002\/cncr.10893.","journal-title":"Cancer."},{"issue":"7","key":"9000_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1349-7006.2002.tb01327.x","volume":"93","author":"N Matsukura","year":"2002","unstructured":"Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, et al. Association between helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Japanese. J Cancer Res. 2002;93(7):842\u20137. https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01327.x.","journal-title":"J Cancer Res"},{"issue":"7","key":"9000_CR11","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1007\/s13277-014-1876-2","volume":"35","author":"R Rai","year":"2014","unstructured":"Rai R, Sharma KL, Misra S, Kumar A, Mittal B. CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users. Tumor Biol. 2014;35(7):6531\u20137. https:\/\/doi.org\/10.1007\/s13277-014-1876-2.","journal-title":"Tumor Biol"},{"issue":"3","key":"9000_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/bjc.2014.579","volume":"112","author":"V Bagnardi","year":"2015","unstructured":"Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112(3):580\u201393. https:\/\/doi.org\/10.1038\/bjc.2014.579.","journal-title":"Br J Cancer"},{"issue":"5","key":"9000_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00534-013-0606-2","volume":"20","author":"Y Morine","year":"2013","unstructured":"Morine Y, Shimada M, Takamatsu H, Araida T, Endo I, Kubota M, et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci. 2013;20(5):472\u201380. https:\/\/doi.org\/10.1007\/s00534-013-0606-2.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"9000_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00535-016-1268-z","volume":"52","author":"T Kamisawa","year":"2017","unstructured":"Kamisawa T, Kuruma S, Chiba K, Tabata T, Koizumi S, Kikuyama M. Biliary carcinogenesis in pancreaticobiliary maljunction. J Gastroenterol. 2017;52(2):158\u201363. https:\/\/doi.org\/10.1007\/s00535-016-1268-z.","journal-title":"J Gastroenterol"},{"issue":"6","key":"9000_CR15","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1111\/j.1572-0241.1999.01155.x","volume":"94","author":"K Hanada","year":"1999","unstructured":"Hanada K, Tsuchida A, Iwao T, Eguchi N, Sasaki T, Morinaka K, et al. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol. 1999;94(6):1638\u201342. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01155.x.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"9000_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s005340200035","volume":"9","author":"T Matsubara","year":"2002","unstructured":"Matsubara T, Sakurai Y, Zhi LZ, Miura H, Ochiai M, Funabiki T. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepato-Biliary-Pancreat Surg. 2002;9(3):312\u201321. https:\/\/doi.org\/10.1007\/s005340200035.","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"issue":"9","key":"9000_CR17","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M, et al. Genomic spectra of biliary tract cancer. Nat Genet. 2015;47(9):1003\u201310. https:\/\/doi.org\/10.1038\/ng.3375.","journal-title":"Nat Genet"},{"issue":"8","key":"9000_CR18","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46(8):872\u20136. https:\/\/doi.org\/10.1038\/ng.3030.","journal-title":"Nat Genet"},{"issue":"8","key":"9000_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/MPA.0000000000001371","volume":"48","author":"S Takano","year":"2019","unstructured":"Takano S, Fukasawa M, Kadokura M, Shindo H, Takahashi E, Hirose S, et al. Mutational patterns in pancreatic juice of intraductal papillary mucinous neoplasms and concomitant pancreatic cancer. Pancreas. 2019;48(8):1032\u201340. https:\/\/doi.org\/10.1097\/MPA.0000000000001371.","journal-title":"Pancreas."},{"issue":"Database issue","key":"9000_CR20","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkq929","volume":"39","author":"SA Forbes","year":"2011","unstructured":"Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2011;39(Database issue):D945\u201350. https:\/\/doi.org\/10.1093\/nar\/gkq929.","journal-title":"Nucleic Acids Res"},{"key":"9000_CR21","doi-asserted-by":"publisher","unstructured":"Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J, et al. OncoKB: a precision oncology knowledge base. JCO Precis Oncol. 2017;2017. https:\/\/doi.org\/10.1200\/PO.17.00011.","DOI":"10.1200\/PO.17.00011"},{"issue":"3","key":"9000_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gut.38.3.426","volume":"38","author":"T Ajiki","year":"1996","unstructured":"Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, et al. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut. 1996;38(3):426\u20139. https:\/\/doi.org\/10.1136\/gut.38.3.426.","journal-title":"Gut."},{"key":"9000_CR23","doi-asserted-by":"publisher","unstructured":"Takano S, Fukasawa M, Kadokura M, Shindo H, Takahashi E, Hirose S, et al. Next-generation sequencing revealed TP53 mutations to be malignant marker for intraductal papillary mucinous neoplasms that could be detected using pancreatic juice. PancreasPublished online. 2017. https:\/\/doi.org\/10.1097\/MPA.0000000000000931.","DOI":"10.1097\/MPA.0000000000000931"},{"key":"9000_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00268-001-0187-0","volume":"26","author":"M Nagai","year":"2002","unstructured":"Nagai M, Watanabe M, Iwase T, Yamao K, Isaji S. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J Surg. 2002;26:91\u20138. https:\/\/doi.org\/10.1007\/s00268-001-0187-0.","journal-title":"World J Surg"},{"issue":"1","key":"9000_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0016-5107(04)01290-8","volume":"60","author":"T Kamisawa","year":"2004","unstructured":"Kamisawa T, Funata N, Hayashi Y, Egawa N, Nakajima H, Tsuruta K, et al. Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel. Gastrointest Endosc. 2004;60(1):56\u201360. https:\/\/doi.org\/10.1016\/S0016-5107(04)01290-8.","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"9000_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00535-012-0611-2","volume":"47","author":"T Kamisawa","year":"2012","unstructured":"Kamisawa T, Ando H, Suyama M, Shimada M, Morine Y, Shimada H. Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol. 2012;47(7):731\u201359. https:\/\/doi.org\/10.1007\/s00535-012-0611-2.","journal-title":"J Gastroenterol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-09000-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-09000-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-09000-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T10:03:07Z","timestamp":1637316187000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-09000-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9000"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-09000-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"19 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Human Ethics Review Committee of Yamanashi University Hospital (Receipt numbers: 1326 and 1523) and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1245"}}